本頁面由Tiger Trade Technology Pte. Ltd.提供服務

爵士製藥

245.80
+5.322.21%
盤後245.800.00000.00%19:30 EDT
成交量:42.29萬
成交額:1.04億
市值:159.56億
市盈率:16.80
高:246.73
開:244.60
低:244.04
收:240.48
52周最高:266.38
52周最低:123.88
股本:6,491.46萬
流通股本:6,269.43萬
量比:0.77
換手率:0.67%
股息:- -
股息率:- -
每股收益(TTM):14.63
每股收益(LYR):-5.8403
淨資產收益率:22.11%
總資產收益率:6.86%
市淨率:3.32
市盈率(LYR):-42.09

資料載入中...

2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/12

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/07

持股變動聲明

Initial statement of beneficial ownership of securities
2019/08/06

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/06

重要事件披露

Current report, items 2.02 and 9.01
2019/06/07

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/04

持股變動聲明

Initial statement of beneficial ownership of securities
2019/05/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/05/07

重要事件披露

Current report, items 2.02 and 9.01
2019/04/26

[修訂]年度報告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2018/11/14

SEC問詢函

[Cover]Correspondence
2018/04/24

[修訂]年度報告

Jazz Pharmaceuticals plc